Altamira Therapeutics Ltd. Cash Flows From Used In Financing Activities Discontinued Operations
Altamira Therapeutics Ltd. (CYTOF) reported Cash Flows From Used In Financing Activities Discontinued Operations of CHF 1.06 million for the 12-month period ending 2023-12-31, per its 20-F/A filed 2024-04-22.
Financial Statements › Notes
ifrs-full:CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations · last filed 2025-04-30
CHF
| Period end | Cash Flows From Used In Financing Activities Discontinued Operations 12 month |
|---|---|
| 2023-12-31 | 1.06M CHF 20-F/A · filed 2024-04-22 |
| 2022-12-31 | 859.61K CHF 20-F/A · filed 2024-04-22 |
| 2021-12-31 | 2.00M CHF 20-F/A · filed 2024-04-22 |
USD
| Period end | Cash Flows From Used In Financing Activities Discontinued Operations 12 month |
|---|---|
| 2023-12-31 | $1.18M 20-F · filed 2025-04-30 |
| 2022-12-31 | $900.12K 20-F · filed 2025-04-30 |